Invesco’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Invesco’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-8,776	Closed	-$1.13M	–	3694
2019 Q2	$1.13M	Sell	8,776 -2,191	-20%	-$260K	﹤0.01%	3002
2019 Q1	$1.29M	Buy	10,967 +945	+9%	+$95.3K	﹤0.01%	2871
2018 Q4	$919K	Buy	+10,022	New	+$1.02M	﹤0.01%	3023
2015 Q3	–	Sell	-839	Closed	-$43K	–	3868
2015 Q2	$43K	Buy	+839	New	+$44.5K	﹤0.01%	3990

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco's LKFT Position: Q3 2019 in Review

Invesco sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2019, closing a stake of 8,776 shares — an estimated $1.13M sold.

Invesco first reported a position in LKFT in Q2 2015 and held it in 4 quarters. The position peaked at $1.29M in Q1 2019. 111 funds tracked by Wall St. Rank hold LKFT as of Q3 2019.

Invesco reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2019 after selling out during the quarter.
Invesco sold 8,776 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2019, an estimated $1.13M.
Invesco first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 4 quarters.
Invesco's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.29M in Q1 2019.
111 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2019.

Based on Invesco's 13F filing for Q3 2019, filed 14 Nov 2019.